RE:RE:RE:RE:RE:RE:Boehringer North AmericaIMHO, that doesn't look good. Why wouldn't they delay that, and collaborate on a trial with PLI? Seems strange they are willing to waste tens of millions of dinero doing a lone trial for a drug that could get its socks knocked off by PLIs trial? Doesn't sound like they are in the mood to collaborate at all, and are staging a fight? Do they have more friends at the FDA than we do?